PHATHOM PHARMACEUTICALS, INC. (PHAT): Price and Financial Metrics
PHATHOM PHARMACEUTICALS, INC. (PHAT)
Today's Latest Price: $29.56 USD
0.13 (0.44%)
Updated Jul 14 11:18am
Add PHAT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PHAT Daily Price Range
PHAT 52-Week Price Range
PHAT Stock Price Chart Technical Analysis Charts
PHAT Price/Volume Stats
| Current price | $29.56 | 52-week high | $64.54 |
| Prev. close | $29.43 | 52-week low | $18.51 |
| Day low | $28.64 | Volume | 12,379 |
| Day high | $30.27 | Avg. volume | 81,573 |
| 50-day MA | $39.80 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 856.21M |
PHATHOM PHARMACEUTICALS, INC. (PHAT) Company Bio
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Buffalo Grove, IL.
Loading social stream, please wait...